LeonaBio (LONA) Other Operating Expenses (2023 - 2026)

LeonaBio (LONA) has reported Other Operating Expenses for 4 consecutive years, with -$929000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 87.87% year-over-year to -$929000.0; the TTM figure through Mar 2026 stood at $80.0 million (up 83.77% YoY), while the FY2025 annual figure was $68.1 million, changed N/A from the prior year.
• Other Operating Expenses eased to -$929000.0 in Q1 2026 per LONA's latest filing, from $86.4 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $86.4 million in Q4 2025 and bottomed at -$24.8 million in Q1 2024.
• Historically, Other Operating Expenses has averaged $12.6 million across 4 years, with a median of -$3.2 million in 2025.
• Annual changes were most pronounced in 2024 — Other Operating Expenses soared 4636.81% — and 2025, when it increased 14.02%.
• LeonaBio's Other Operating Expenses stood at $1.6 million in 2023, then jumped by 4636.81% to $75.8 million in 2024, then advanced by 14.02% to $86.4 million in 2025, then tumbled by 101.08% to -$929000.0 in 2026.
• Business Quant data shows LONA's Other Operating Expenses at -$929000.0 in Q1 2026, $86.4 million in Q4 2025, and -$5.5 million in Q2 2025.